Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The protective function of Ly6Clo monocytes in AD may also explain why CCR2 deficiency exacerbates disease severity [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“CCR2 deficiency worsened AD pathology [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“studies utilizing whole body irradiation chimeras, an experimental technique that is now recognized to condition the brain for monocyte infiltration [2, 3, 230], as well as transplant of BM-derived cells, reported that Ly6Chi monocytes infiltrate the AD mouse brain and accumulate around Aβ plaques.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“These infiltrating cells were thought to ameliorate disease evolution by phagocytosis and clearance of Aβ from the brain parenchyma [287] or by promotion of CCR2-mediated microglial accumulation in amyloid plaques and degradation of Aβ [89].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“Marrow-derived cells may have an ameliorative effect on neurodegenerative phenotypes in mice33,34, possibly due to their superior phagocytic capacity35.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [34]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are chemotactic cytokines that bind specific G protein–coupled receptors on the surface of cells and mediate the accumulation of leukocytes at sites of inflammatio”
BackgroundBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Cited by
Items 401–500 of 940
Characterization of the role of metallothionein-3 in an animal model of Alzheimer’s disease
Manso, Y., Carrasco, J., Comes, G., Meloni, G., Adlard, P. A., Bush, A. I., Vašák, M., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1047-9 · Cited by 63
Ajit, D., Woods, L. T., Camden, J. M., Thebeau, C. N., El-Sayed, F. G., Greeson, G. W., Erb, L., Petris, M. J., Miller, D. C., Sun, G. Y., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8577-5 · Cited by 66
Takata, K., Takada, T., Ito, A., Asai, M., Tawa, M., Saito, Y., Ashihara, E., Tomimoto, H., Kitamura, Y., & Shimohama, S. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/685739 · Cited by 71
Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease
Goldeck, D., Larbi, A., Pellicanò, M., Alam, I., Zerr, I., Schmidt, C., Fülöp, T., & Pawelec, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066664 · Cited by 64
Piotrowska, A., Kwiatkowski, K., Rojewska, E., Ślusarczyk, J., Makuch, W., Basta‐Kaim, A., Przewłocka, B., & Mika, J. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.017 · Cited by 60
Gabbita, S. P., Johnson, M. F., Kobritz, N., Eslami, P., Poteshkina, A., Varadarajan, S., Turman, J., Zemlan, F., & Harris-White, M. E. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137305 · Cited by 60
Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway
Liang, J., Takeuchi, H., Jin, S., Noda, M., Li, H., Doi, Y., Kawanokuchi, J., Sonobe, Y., Mizuno, T., & Suzumura, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.083 · Cited by 68
Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
Al‐Onaizi, M., Al-Khalifah, A., Qasem, D., & ElAli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186875 · Cited by 63
Immune cells may fend off Alzheimer disease
Britschgi, M., & Wyss‐Coray, T. (2007) · Nature Medicine · doi:10.1038/nm0407-408 · Cited by 62
Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
Meyer‐Luehmann, M., & Prinz, M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.011 · Cited by 59
Plagg, B., Ehrlich, D., Kniewallner, K. M., Marksteiner, J., & Humpel, C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710114256 · Cited by 61
Epigenetic Regulation of Neuroinflammation in Alzheimer’s Disease
Ma, Y., Wang, W., Liu, S., Qiao, X., Xing, Y., Zhou, Q., & Zhang, Z. (2023) · Cells · doi:10.3390/cells13010079 · Cited by 61
Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain
Choi, S.-H., Aïd, S., Choi, U., & Bosetti, F. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.68 · Cited by 57
Kraus, B., Wolff, H., Heilmann, J., & Elstner, E. F. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.020 · Cited by 63
γ‐Secretase component presenilin is important for microglia β‐amyloid clearance
Farfara, D., Trudler, D., Segev‐Amzaleg, N., Galron, R., Stein, R., & Frenkel, D. (2011) · Annals of Neurology · doi:10.1002/ana.22191 · Cited by 57
Zhang, L., Tan, J., Jiang, X., Qian, W., Yang, T., Sun, X., Chen, Z., & Zhu, Q. (2017) · Biological Research · doi:10.1186/s40659-017-0130-y · Cited by 57
Blood Protein Signature for the Early Diagnosis of Alzheimer Disease
Britschgi, M., & Wyss‐Coray, T. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.530 · Cited by 62
Neuroprotective roles of the P2Y2 receptor
Weisman, G. A., Ajit, D., Garrad, R. C., Peterson, T. S., Woods, L. T., Thebeau, C. N., Camden, J. M., & Erb, L. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9307-6 · Cited by 63
Hallmarks of neurodegenerative disease: A systems pharmacology perspective
Bloomingdale, P., Karelina, T., Ramakrishnan, V., Bakshi, S., Véronneau‐Veilleux, F., Moye, M., Sekiguchi, K., Meno‐Tetang, G. M. L., Mohan, A., Maithreye, R., et al. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12852 · Cited by 67
Passos, G. F., Figueiredo, C. P., Prediger, R. D., Silva, K. A. B. S., Siqueira, J. M., Duarte, F. S., Leal, P. C., Medeiros, R., & Calixto, J. Β. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.12.003 · Cited by 63
Neural stem/progenitor cells in Alzheimer's disease.
Tincer, G., Mashkaryan, V., Bhattarai, P., & Kızıl, Ç. (2016) · PubMed Central · Cited by 65
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Delgado-Olmos, I., Gamero-Carrasco, C., Fernández-Ponce, M. T., Casas, L., Mantell, C., & García-Alloza, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0015-z · Cited by 56
Wruck, W., & Adjaye, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00907-8 · Cited by 59
Yamanaka, G., Morıchı, S., Takamatsu, T., Watanabe, Y., Suzuki, S., Ishida, Y., Oana, S., Yamazaki, T., Takata, F., & Kawashima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094395 · Cited by 57
Evolution of Siglec-11 and Siglec-16 Genes in Hominins
Wang, X., Mitra, N., Cruz, P., Deng, L., Program, N. C. S., Varki, N., Angata, T., Green, E. D., Mullikin, J., Hayakawa, T., et al. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss077 · Cited by 55
Owlett, L. D., Karaahmet, B., Le, L., Belcher, E. K., Dionisio-Santos, D. A., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02397-y · Cited by 56
Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
Battaglini, M., Marino, A., Montorsi, M., Carmignani, A., Ceccarelli, M. C., & Ciofani, G. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202304180 · Cited by 58
Vaccination as a Therapeutic Approach to Alzheimer's Disease
Wisniewski, T., & Boutajangout, A. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20156 · Cited by 51
Castellani, G., & Schwartz, M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.005 · Cited by 55
Monocytes and Alzheimer’s disease
Feng, Y., Li, L., & Sun, X. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1205-3 · Cited by 62
Contributions of monocytes to nervous system disorders
Garré, J. M., & Yang, G. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1672-3 · Cited by 57
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 54
Imaging of Leukocyte Trafficking in Alzheimer’s Disease
Pietronigro, E. C., Zenaro, E., & Constantin, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00033 · Cited by 54
Tan, Y. J., Ng, A. S. L., Vipin, A., Lim, J. K. W., Chander, R. J., Ji, F., Qiu, Y., Ting, S. K. S., Hameed, S., Lee, T.-S., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161277 · Cited by 55
Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention
Schelke, M. W., Attia, P., Palenchar, D. J., Kaplan, B., Mureb, M., Ganzer, C. A., Scheyer, O., Rahman, A., Kachko, R., Krikorian, R., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00096 · Cited by 56
Martín‐Sánchez, A., Piñero, J., Nonell, L., Arnal, M., Ribé, E. M., Nevado‐Holgado, A. J., Lovestone, S., Sanz, F., Furlong, L. I., & Valverde, O. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00810-x · Cited by 56
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 54
Pimentel‐Coelho, P. M., Michaud, J.-P., & Rivest, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.025 · Cited by 57
Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
Bossù, P., Spalletta, G., Caltagirone, C., & Ciaramella, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00632 · Cited by 54
Rotterman, T. M., Akhter, E. T., Lane, A. R., MacPherson, K. P., García, V. V., Tansey, M. G., & Álvarez, F. J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2945-17.2019 · Cited by 61
Targeting the Endocannabinoid System in Alzheimer's Disease
Koppel, J. L., & Davies, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15315 · Cited by 57
Mechanisms of myeloid cell entry to the healthy and diseased central nervous system
Amann, L., Masuda, T., & Prinz, M. (2023) · Nature Immunology · doi:10.1038/s41590-022-01415-8 · Cited by 50
Wyatt-Johnson, S. K., & Brutkiewicz, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.592359 · Cited by 50
Shi, M., Chu, F., Zhu, F., & Zhu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03003-5 · Cited by 54
In Vivo Imaging of Microglia With Multiphoton Microscopy
Hierro‐Bujalance, C., Bacskai, B. J., & García-Alloza, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00218 · Cited by 52
Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 56
Impact of the CD40-CD40L Dyad in Alzheimers Disease
Giunta, B. N., Rezai-Zadeh, K. P., & Tan, J. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012099 · Cited by 56
Kokiko-Cochran, O., Ransohoff, L., Veenstra, M., Lee, S., Saber, M., Sikora, M., Teknipp, R., Xu, G., Bemiller, S., Wilson, G., et al. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.3970 · Cited by 49
Elucidating pathway-selective biased CCKBR agonism for Alzheimer’s disease treatment
Wang, J., Sha, X.-Y., Shao, Y., Zhang, Z.-H., Huang, S.-M., Lin, H., Gan, S., Zhang, N., Xia, X., Sun, Y.-N., et al. (2025) · Cell · doi:10.1016/j.cell.2025.10.034 · Cited by 56
Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration
Bosco, D. B., Tian, D., & Wu, L. (2020) · FEBS Journal · doi:10.1111/febs.15428 · Cited by 57
Basic Aspects of the Immunology of Neuroinflammation
Wohleb, E. S., & Godbout, J. P. (2013) · Modern trends in psychiatry · doi:10.1159/000343964 · Cited by 60
Michaud, J.-P., Richard, K. L., & Rivest, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-5 · Cited by 48
“MCP-1 (CCL2) is a major chemiokine involved in the recruitment of monocytes in AD patients [43,44] and in mouse models of this pathology [45,46].”
BackgroundMcFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48
Deficiency of a sulfotransferase for sialic acid-modified glycans mitigates Alzheimer’s pathology
Zhang, Z., Takeda‐Uchimura, Y., Foyez, T., Ohtake‐Niimi, S., Narentuya, Akatsu, H., Nishitsuji, K., Michikawa, M., Wyss‐Coray, T., Kadomatsu, K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615036114 · Cited by 53
Li, S., Hayden, E. Y., Garcia, V. J., Fuchs, D.-T., Sheyn, J., Daley, D. A., Rentsendorj, A., Torbati, T., Black, K. L., Rutishauser, U., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00049 · Cited by 51
Crehan, H., Liu, B., Kleinschmidt, M., Rahfeld, J., Le, K. X., Caldarone, B. J., Frost, J. L., Hettmann, T., Hutter‐Paier, B., O’Nuallain, B., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0579-8 · Cited by 50
Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells
Wang, L., Jiang, Q., Chu, J., Lin, L., Li, X.-G., Chai, G.-S., Wang, Q., Wang, J.-Z., & Tian, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076057 · Cited by 47
Suzzi, S., Croese, T., Ravid, A., Gold, O., Clark, A. R., Medina, S., Kitsberg, D., Adam, M., Vernon, K. A., Kohnert, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36759-8 · Cited by 49
Cudaback, E., Yang, Y., Montine, T. J., & Keene, C. D. (2015) · Glia · doi:10.1002/glia.22732 · Cited by 47
Doustar, J., Rentsendorj, A., Torbati, T., Regis, G. C., Fuchs, D.-T. S., Sheyn, J., Mirzaei, N., Graham, S. L., Shah, P. K., Mastali, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13246 · Cited by 47
Ramesha, S., Rayaprolu, S., Bowen, C. A., Giver, C. R., Bitarafan, S., Nguyen, H. M., Gao, T., Chen, M. J., Nwabueze, N. V., Dammer, E. B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013545118 · Cited by 52
A limited role for microglia in antibody mediated plaque clearance in APP mice
García-Alloza, M., Ferrara, B. J., Dodwell, S. A., Hickey, G. A., Hyman, B. T., & Bacskai, B. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.019 · Cited by 50
Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46
“This result may reflect the balance between the need for immune recruitment to protect neurons and the detrimental effects of excessive or prolonged immune activation (El Khoury et al., 2007).”
Ciechanowska, A., & Mika, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073788 · Cited by 54
Park, J., Baik, S. H., Mook-Jung, I., Irimia, D., & Cho, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02231 · Cited by 47
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 45
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
Ben-Yehuda, H., Arad, M., Ramos, J. M. P., Sharon, E., Castellani, G., Ferrera, S., Cahalon, L., Colaiuta, S. P., Salame, T., & Schwartz, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00458-z · Cited by 46
Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques
Galea, E., Morrison, W., Hudry, E., Arbel‐Ornath, M., Bacskai, B. J., Gómez‐Isla, T., Stanley, E., & Hyman, B. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516779112 · Cited by 49
Xiao, J., Zhu, T., Yin, Y.-Z., & Sun, B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.004 · Cited by 51
Blume, T., Focke, C., Peters, F., Deussing, M., Albert, N. L., Lindner, S., Gildehaus, F.-J., von Ungern-Sternberg, B., Ozmen, L., Baumann, K., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1347-6 · Cited by 45
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 47
Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K., Hammock, B., & Pellegrini, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
The Roles of Monocyte and Monocyte‐Derived Macrophages in Common Brain Disorders
Zhao, M., Tuo, H., Wang, S., & Zhao, L. (2020) · BioMed Research International · doi:10.1155/2020/9396021 · Cited by 48
Stem cell therapy for central nerve system injuries: glial cells hold the key
Xiao, L., Saiki, C., & Ide, R. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.137570 · Cited by 50
Immune-mediated processes in neurodegeneration: where do we stand?
Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 54
Matsye, P. D., Zheng, L., Si, Y., Kim, S., Luo, W., Crossman, D. K., Bratcher, P. E., & King, P. H. (2017) · Glia · doi:10.1002/glia.23137 · Cited by 44
Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
Wang, H., Shen, Y., Chuang, H., Chiu, C., Ye, Y., & Zhao, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503151648 · Cited by 41
Yang, Q., Wu, B., Eles, J. R., Vazquez, A. L., Kozai, T. D. Y., & Cui, X. T. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900287 · Cited by 47
Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls
Cisbani, G., & Rivest, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01083-4 · Cited by 46
Fonseca, M. I., McGuire, S. O., Counts, S., & Tenner, A. J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-25 · Cited by 45
Blood Leukocyte Counts in Alzheimer Disease
Luo, J. M., Thomassen, J. Q., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.35648 · Cited by 47
Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
Town, T. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787847306 · Cited by 42
Naert, G., & Rivest, S. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00051 · Cited by 49
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Lee, J., Cho, E., Seo, J.-W., Hwang, J. J., & Koh, J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182417387 · Cited by 44
Ahmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C. M., Chial, H. J., & Potter, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718426 · Cited by 43
Monocyte mobilisation, microbiota & mental illness
van de Wouw, M., Boehme, M., Dinan, T. G., & Cryan, J. F. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.019 · Cited by 42
Presenilin 1 phosphorylation regulates amyloid-β degradation by microglia
Ledo, J. H., Liebmann, T., Zhang, R., Chang, J. C., Azevedo, E. P., Wong, E., Silva, H. M., Troyanskaya, O. G., Bustos, V., & Greengard, P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0856-8 · Cited by 47
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 43
Zhang, X., Ye, P., Wang, D., Liu, Y., Cao, L., Wang, Y., Xu, Y., & Zhu, C. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00668-6 · Cited by 40
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer’s disease
Abellanas, M. A., Purnapatre, M., Burgaletto, C., & Schwartz, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01847-5 · Cited by 42
Complex role of chemokine mediators in animal models of Alzheimer's Disease
Martin, E., & Delarasse, C. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.002 · Cited by 42
Puntambekar, S. S., Davis, D. S., Hawel, L., Crane, J., Byus, C. V., & Carson, M. J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.016 · Cited by 39
Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex
Leung, E., Guo, L., Bu, J., Maloof, M., Khoury, J. E., & Geula, C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.025 · Cited by 40
Self-citationPossible Therapeutic Uses of Salvia triloba and Piper nigrum in Alzheimer's Disease–Induced Rats
Ahmed, H. H., Salem, A. M. H., Sabry, G. M., Husein, A. A., & Kotob, S. E. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0165 · Cited by 41
Kawahara, K., Nishi, K., Suenobu, M., Ohtsuka, H., Maeda, A., Nagatomo, K., Kuniyasu, A., Staufenbiel, M., Nakagomi, M., Shudo, K., et al. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1307 · Cited by 38
Kajiwara, Y., McKenzie, A. T., Dorr, N. P., Sosa, M. A. G., Elder, G. A., Schmeidler, J., Dickstein, D. L., Bozdagi, O., Zhang, B., & Buxbaum, J. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw265 · Cited by 44
Current Therapeutic Targets for Alzheimer's Disease
Chaudhary, A., Maurya, P. K., Yadav, B. S., Singh, S., & Mani, A. (2018) · Journal of Biomedicine · doi:10.7150/jbm.26783 · Cited by 43
Emerging Roles for G-protein Coupled Receptors in Development and Activation of Macrophages
Wang, X., Iyer, A., Lyons, A. B., Körner, H., & Wei, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02031 · Cited by 43
Metadata
- Authors
- El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
- Affiliations
- Okayama University (JP)
- Northwestern University (US)
- Corresponding author
- Luster, Andrew D
- Venue
- Nature Medicine
- Published
- 2007-03-11
- Volume
- 13
- Issue
- 4
- Pages
- 432-438
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097867538
- Cited by
- 915
- References
- 51
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Dana Foundation
- Gladstone Institutes
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.